Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Effectiveness of Dry Needling in Shortened Triceps Surae Muscle (DN-TS)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03273985
Recruitment Status : Completed
First Posted : September 6, 2017
Last Update Posted : December 8, 2017
Sponsor:
Collaborator:
Universidad Complutense de Madrid
Information provided by (Responsible Party):
César Calvo Lobo, Universidad de León

Brief Summary:
To date, there are not studies about the effectiveness of dry needling versus ischemic compression in the triceps surae trigger points. A randomized clinical trial is carried out. A sample of 30 subjects are recruited and allocated into dry needling (n = 15) and ischemic compression (n = 15). Outcome measurements such as dorsal flexion range of motion, plantar pressures, temperature, superficial muscle activity and trigger points pressure pain threshold are measured immediately before and after treatment.

Condition or disease Intervention/treatment Phase
Trigger Point Pain, Myofascial Myofascial Pain Syndrome Other: Dry needling Other: Ischemic compression Not Applicable

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 30 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single (Outcomes Assessor)
Primary Purpose: Treatment
Official Title: Effectiveness of Deep Dry Needling in Subjects With Shortened Triceps Surae Originated by Myofascial Pain Syndrome
Actual Study Start Date : September 15, 2017
Actual Primary Completion Date : December 6, 2017
Actual Study Completion Date : December 6, 2017

Resource links provided by the National Library of Medicine


Arm Intervention/treatment
Experimental: Dry needling Other: Dry needling
Trigger point deep dry needling

Experimental: Ischemic compression Other: Ischemic compression
Trigger point ischemic compression




Primary Outcome Measures :
  1. Range of motion [ Time Frame: Change from Baseline Range of motion at 25 minutes ]
    Ankle dorsal flexion by means of the goniometer


Secondary Outcome Measures :
  1. Plantar pressures [ Time Frame: Change from Baseline Plantar pressures at 25 minutes ]
    Plantar pressures platform

  2. Temperature [ Time Frame: Change from Baseline Temperature at 25 minutes ]
    Thermal imaging

  3. Superficial muscle activity [ Time Frame: Change from Baseline Superficial muscle activity at 25 minutes ]
    Electromyography

  4. Pressure pain threshold [ Time Frame: Change from Baseline Pressure pain threshold at 25 minutes ]
    Algometer



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 70 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Myofascial pain syndrome in the triceps surae muscle, limitation of ankle dorsal flexion range of motion.

Exclusion Criteria:

  • Neurologic disorders, pharmacologic treatment (within the previous 3 months), cognitive impairment, prosthesis in the lower limb, systemic or infectious diseases, autoimmune diseases, fibromyalgia, hypothyroidism, anticoagulants or antiplatelet agents, and fear of needles.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03273985


Locations
Layout table for location information
Spain
Fisiofuenla
Fuenlabrada, Madrid, Spain, 28943
Sponsors and Collaborators
Universidad de León
Universidad Complutense de Madrid

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Layout table for additonal information
Responsible Party: César Calvo Lobo, Professor, PhD, MSc, PT, Universidad de León
ClinicalTrials.gov Identifier: NCT03273985    
Other Study ID Numbers: DN-TS-UCM
First Posted: September 6, 2017    Key Record Dates
Last Update Posted: December 8, 2017
Last Verified: December 2017
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Additional relevant MeSH terms:
Layout table for MeSH terms
Myofascial Pain Syndromes
Fibromyalgia
Syndrome
Disease
Pathologic Processes
Muscular Diseases
Musculoskeletal Diseases
Rheumatic Diseases
Neuromuscular Diseases
Nervous System Diseases